Mark James Litton Insider Trading $ATHA Athira Pharma, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark James Litton.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark James Litton. Mark James Litton is Chief Business Officer in ALDER BIOPHARMACEUTICALS INC ($ALDR) and Chief Operating Officer in Athira Pharma, Inc. ($ATHA) and See Remarks in ALPINE IMMUNE SCIENCES, INC. ($ALPN).
Mark James Litton in Athira Pharma, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Mark James Litton: Chief Operating Officer
Holdings: 63,566 shares
Latest Transaction: Feb 22 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Mark James Litton in Athira Pharma, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALDR, ALPN, ATHA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 22 2021 | ATHA | Athira Pharma, Inc ... | Litton Mark James | Chief Operating Off ... | Option Exercise | A | 21.15 | 85,000 | 1,797,750 | 85,000 | |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | Litton Mark James | Chief Operating Off ... | Option Exercise | C | 0.00 | 6,563 | 0 | 0 | |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | Litton Mark James | Chief Operating Off ... | Option Exercise | C | 0.00 | 6,563 | 0 | 0 | |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | Litton Mark James | Chief Operating Off ... | Option Exercise | C | 0.00 | 6,563 | 0 | 0 | |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | Litton Mark James | Chief Operating Off ... | Option Exercise | C | 0.00 | 13,126 | 0 | 0 | |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | Litton Mark James | Chief Operating Off ... | Buy | C | 0.00 | 6,563 | 0 | 6,563 | 0 to 6.6 K |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | Litton Mark James | Chief Operating Off ... | Buy | C | 0.00 | 6,563 | 0 | 6,563 | 0 to 6.6 K |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | Litton Mark James | Chief Operating Off ... | Buy | C | 0.00 | 6,563 | 0 | 6,563 | 0 to 6.6 K |
| Sep 22 2020 | ATHA | Athira Pharma, Inc ... | Litton Mark James | Chief Operating Off ... | Buy | C | 0.00 | 13,126 | 0 | 63,566 | 50.4 K to 63.6 K (+26.02 %) |
Page: 1